DwainFullerMDJD

Ophthalmology • Dallas, TX

Retinal Disease, Ocular Oncology

Partner Texas Retina Associates

Join to view full profile

Dr. Fuller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fuller's full profile

Already have an account?

Office
9600 N. Central Expressway
Suite 100
Dallas, TX 75231
Phone+1 214-692-6941

Education & Training

University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 1973 - 1975
University of California (San Francisco)Residency, Ophthalmology, 1970 - 1973
University of Virginia Medical CenterResidency, Internal Medicine, 1966 - 1968
Baylor College of MedicineClass of 1966

Certifications & Licensure

CA State Medical License 1971 - Present
TX State Medical License 1971 - 2025
FL State Medical License 1975 - 1989
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
Super Doctor SuperDoctors.com
Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy. Start of enrollment: 2014 Sep 23
Completed
Phase 2

Publications & Presentations

PubMed

4 citations
Two-year results for ranibizumab for radiation retinopathy (RRR): a randomized, prospective trial
Hannah J. Yu, Dwain G. Fuller, Rajiv Anand, Timothy Fuller, Jose Munoz
Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2021-08-31
14 citations
Randomized Trial of Monthly Versus As-Needed Intravitreal Ranibizumab for Radiation Retinopathy-Related Macular Edema: 1-Year Outcomes.
Amy C Schefler, Dwain G. Fuller, Rajiv Anand, Timothy Fuller, Chelsey Moore
American Journal of Ophthalmology. 2020-08-01
37 citations
Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17
Jeannette J. Yu, Elvira Agrón, Traci E. Clemons, Amitha Domalpally, Freekje van Asten
Ophthalmology. 2019-02-01

Authored Content

Randomized Trial of Monthly Versus as-Needed Intravitreal Ranibizumab for Radiation Retinopathy-Related Macular Edema: 1 Year OutcomesApril 2020

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow